Regimes of pharmaceutical governance

Tineke Kleinhout-Vliek

Chapter 21 in Handbook of Pharmaceutical Science and Technology Studies, 2026, pp 341-349 from Edward Elgar Publishing

Abstract: Over the course of this volume, we have encountered a multitude of actors, all entangled in pharmaceutical governance in some way. Pharmaceutical governance, or the work behind the conception, installation, maintenance, dismantling, and ensuring other actors’ adherence to, pharmaceutical regulation (standards, rules, policies, directives, laws, etc.), is organized in regimes. These regimes are made up of actors situated across different scales: local, national, supranational, and global. They also comprise actors in varying roles. Not just governments, ministries, and arm's length bodies but also pharmaceutical companies, patient organizations, healthcare insurers, civil society, and many more routinely have a say in the governance of pharmaceuticals. These regimes of pharmaceutical governance are thus highly networked and polycentric, boasting different centers of power. The chapters in this Part build on Science and Technology Studies scholarship to deal with the governance of different aspects of the pharmaceutical lifecycle as organized in these regimes, showing different “corners” and emphasizing different contextualized dynamics. Together, the authors speak to three themes: the roles that governance bodies come to occupy in the context of institutional change, how regulation might jump scales and cross borders, and the role of valuation and inclusion practices in pharmaceutical governance.

Keywords: Pharmaceutical regulation; Pharmaceutical governance; Science and Technology Studies; Regimes; Institutional change; Valuation studies (search for similar items in EconPapers)
Date: 2026
ISBN: 9781035338443
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/doi/10.4337/9781035338450.00033 (application/pdf)
Our link check indicates that this URL is bad, the error code is: 403 Forbidden

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:23545_22

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Jack Sweeney ().